Pacer Advisors, Inc. Novo Nordisk A S Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pacer Advisors, Inc. holds 26,890 shares of NVO stock, worth $2.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,890

Previous 26,846 0.16%

Holding current value

$2.37 Million

Previous $3.2 Million 27.63%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$85.0 - $120.04 $3,740 - $5,281	44 Added 0.16%	26,890 $2.31 Million
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $154,195 - $188,318	-1,295 Reduced 4.6%	26,846 $3.2 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $108,598 - $130,015	-885 Reduced 3.05%	28,141 $4.02 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $69,434 - $92,425	-680 Reduced 2.29%	29,026 $3.73 Million
Q4 2023 Jan 16, 2024	BUY	$87.78 - $105.45 $1.29 Million - $1.55 Million	14,702 Added 97.99%	29,706 $3.07 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $133,863 - $293,722	1,472 Added 10.88%	15,004 $1.36 Million
Q2 2023 Jul 12, 2023	BUY	$155.98 - $172.65 $127,591 - $141,227	818 Added 6.43%	13,532 $2.19 Million
Q1 2023 May 02, 2023	BUY	$132.34 - $159.14 $53,994 - $64,929	408 Added 3.32%	12,714 $2.02 Million
Q4 2022 Feb 06, 2023	BUY	$102.55 - $135.33 $1.26 Million - $1.67 Million	12,306 New	12,306 $1.67 Million
Q1 2022 Apr 05, 2022	SELL	$93.1 - $112.54 $1.18 Million - $1.43 Million	-12,676 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$95.88 - $117.08 $38,256 - $46,714	-399 Reduced 3.05%	12,676 $1.42 Million
Q3 2021 Oct 15, 2021	BUY	$84.42 - $106.62 $34,443 - $43,500	408 Added 3.22%	13,075 $1.26 Million
Q2 2021 Jul 21, 2021	SELL	$67.66 - $84.76 $6,766 - $8,476	-100 Reduced 0.78%	12,667 $1.06 Million
Q1 2021 Apr 05, 2021	SELL	$67.06 - $75.82 $45,936 - $51,936	-685 Reduced 5.09%	12,767 $861,000
Q4 2020 Jan 20, 2021	SELL	$63.89 - $73.8 $192,564 - $222,433	-3,014 Reduced 18.3%	13,452 $940,000
Q3 2020 Oct 19, 2020	BUY	$63.69 - $70.22 $1.05 Million - $1.16 Million	16,466 New	16,466 $1.14 Million
Q1 2020 Apr 23, 2020	SELL	$49.46 - $64.78 $623,196 - $816,228	-12,600 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $175,008 - $204,492	3,510 Added 38.61%	12,600 $729,000
Q3 2019 Oct 10, 2019	BUY	$47.54 - $53.43 $136,439 - $153,344	2,870 Added 46.14%	9,090 $470,000
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $291,033 - $326,363	6,220 New	6,220 $317,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $55,229 - $62,434	-1,162 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$41.15 - $49.22 $47,816 - $57,193	1,162	1,162 $56,000

Others Institutions Holding NVO

# of Institutions

1,904

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Novo Nordisk A S Transaction History